http://www.sciencedaily.com/releases...0423162227.htm

Intravenous Vaccination Promotes Brain Plasticity and Prevents Memory Loss in Alzheimer's Disease


Alzheimer's disease (AD) is an incurable, progressive neurodegenerative disease affecting over five million people worldwide, and is the leading cause of dementia in the elderly. Currently, intravenous human immunoglobulin (IVIG) treatment is being explored in multiple off-label uses other than immunotherapy, including AD. Several clinical studies assessing the tolerability and efficacy of IVIG in Alzheimer's disease subjects are in progress with inconsistent outcomes....

"We now have the much needed information supporting the potential application of slow release of immunoglobulins delivered subcutaneously to delay the onset of Alzheimer's disease, even at pre-symptomatic stages of the disease" said Dr. Pasinetti....

Dr. Pasinetti hypothesizes that the slow release of immuglobulins into the circulation and eventually into the brain for a protracted period of time may delay Alzheimer's disease dementia onset and eventually its progression...